RISKLICK

Risklick is develops a first-of-the-kind data-driven tool to allow end-users to identify similar Clinical trials(CTs) and assess risks in early steps of the protocol design. CTs are used to determine the efficacy and safety of an experimental treatment; however, up to 90% of them fail in the early stage of protocol design and the nature and complexity of CTs make risk assessment difficult and time-consuming.

#SimilarOrganizations #Website #More

RISKLICK

Industry:
Clinical Trials Software

Address:
Bern, Bern, Switzerland

Country:
Switzerland

Website Url:
http://www.risklick.ch

Status:
Active

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default LetsEncrypt Mobile Non Scaleable Content Nginx Euro Gatsby JS


Similar Organizations

sealed-envelope-logo

Sealed Envelope

Sealed Envelope offers online software applications, databases and randomization for clinical trials.

Official Site Inspections

http://www.risklick.ch

  • Host name: server-18-160-41-2.iad55.r.cloudfront.net
  • IP address: 18.160.41.2
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Risklick"

Risklick

Powered by a comprehensive database of over 800,000 clinical trials, accurately linked to publications, regulatory approvals, safety data, and various other sources. Easily integrates โ€ฆSee details»

Risklick AG โ€“ Swiss Biotech

Risklick is shaping the future of clinical trial protocols by offering the first-of-its-kind, AI-based tool for developing high-quality clinical trial protocols and โ€ฆSee details»

Protocol AI launch event - Risklick

Apr 23, 2024ย ยท Risklick, a spin-off from the University of Bern, today launched its latest product, Protocol AI. Protocol AI is the first software of its kind and marks a turning point in the โ€ฆSee details»

Contact Us | Risklick AG

Risklick pioneers a revolution in clinical trials with its first-in-class software, leveraging artificial intelligence to serve as experts' co-pilot, enabling swift and effective development of high โ€ฆSee details»

Risklick - LinkedIn

Risklick | 1,178 followers on LinkedIn. Develop the Clinical Trial Protocols of the Future Using AI | Discover the first-in-class AI software reinventing clinical trial protocol development.See details»

Risklick - Crunchbase Company Profile & Funding

Risklick is develops a first-of-the-kind data-driven tool to allow end-users to identify similar Clinical trials (CTs) and assess risks in early steps of the protocol design. CTs are used to determine โ€ฆSee details»

Risklick - SARECO

Risklick, a company based in Bern, pioneers AI solutions for clinical trial risk analysis. The data-driven tool empowers biopharma companies, CROs, and hospitals to identify similar trials and โ€ฆSee details»

Risklick launches flagship product following an investment by โ€ฆ

Apr 24, 2024ย ยท Utilizing artificial intelligence, Risklickโ€™s Protocol AI accelerates clinical trial development, reduces costs, and enhances safety standards. Several established companies โ€ฆSee details»

Risklick - BIO International Convention | BIO

Risklick developed the first of its kind, data-driven solution to design and optimize clinical trial protocols using AI. We empower experts to optimize medical and operational aspects of any โ€ฆSee details»

Risklick Company Profile 2024: Valuation, Funding & Investors

Information on valuation, funding, cap tables, investors, and executives for Risklick. Use the PitchBook Platform to explore the full profile.See details»

Revolution in the pharmaceutical industry? Swiss startup launches โ€ฆ

Apr 30, 2024ย ยท Risklick, a spin-off from the University of Bern, launched Protocol AI, the first software of its kind, marking a turning point in the pharmaceutical industry. Utilizing artificial โ€ฆSee details»

Risklick: Protocol AI accelerates clinical trial development and ...

Apr 23, 2024ย ยท Risklick, a spin-off of the University of Bern, empowers biopharmaceutical and medical device companies to enhance trial success rates and accelerate the delivery of new โ€ฆSee details»

Company profile from RisKlick SA on jobup.ch

Risklick is shaping the future of clinical trial protocols by offering the first-of-its-kind, AI-based tool for developing high-quality synopsis and optimizing clinical trial protocols efficiently, using โ€ฆSee details»

Risklick - Company Profile - Tracxn

1 day agoย ยท Risklick - AI-powered software revolutionizing clinical trials. Risklick has 307 competitors.See details»

Risklick AG - startupticker.ch

Aug 25, 2020ย ยท Risklick AG is tackling the problem of high clinical trial failure (90%) which impose huge financial and ethical burden to companies and volunteers. We are utilizing artificial โ€ฆSee details»

Contact us | Risklick AG

Risklick pioneers a revolution in clinical trials with its first-in-class software, leveraging artificial intelligence to serve as experts' co-pilot, enabling swift and effective development of high โ€ฆSee details»

Risklick AG - startup.ch

Risklick AG is tackling the problem of high clinical trial failure (90%) which impose huge financial and ethical burden to companies and volunteers. We are utilizing artificial intelligence and โ€ฆSee details»

Risklick

Organization Admin: Manages the team, grants access, assigns roles, and can remove users. Creator: Creates new projects, modifies data, and manages content. Reviewer: Accesses โ€ฆSee details»

(PDF) Reducing systematic review burden using Deduklick: a novel ...

Aug 17, 2022ย ยท To address issues related to manual deduplication, we developed an automated, efficient, and rapid artificial intelligence-based algorithm named Deduklick. Deduklick โ€ฆSee details»

Deduklick - risklick.ch

Deduklick is a transparent fully automated deduplication solution created to efficiently remove duplicate records using AI.See details»

linkstock.net © 2022. All rights reserved